T ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for T ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new T ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for T ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New chemo cocktail aims to beat tough blood cancers
Disease control Recruiting nowThis study tests a powerful mix of chemotherapy drugs plus nelarabine in people with untreated T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma. The goal is to see how well the treatment kills cancer cells and what side effects occur. About 160 adults will take part,…
Matched conditions: T ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:58 UTC
-
New chemo cocktail targets tough leukemia in adults
Disease control Recruiting nowThis study tests a combination of chemotherapy drugs (DA-EPOCH) plus an enzyme called asparaginase (Rylaze) in adults newly diagnosed with a type of leukemia called Philadelphia chromosome-negative ALL. The goal is to see if this treatment can kill more cancer cells and help pati…
Matched conditions: T ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated May 20, 2026 11:56 UTC